Prevention of Rh-haemolytic disease: results of the clinical trial. A combined study from centres in England and Baltimore.
D000017:ABO Blood-Group System; D000917:Antibody Formation; D002986:Clinical Trials as Topic; D004739:England; D004899:Erythroblastosis, Fetal / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D008396:Maryland; D011247:Pregnancy; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins / Q000627:therapeutic use*
D000017:ABO Blood-Group System; D012204:Rh-Hr Blood-Group System; D005719:gamma-Globulins